5Herwaldt B L. Leishmaniasis. Lancet, 1999,354:1191-1199
6Berman J D. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis, 1997,24(4) :684-703
7Lira R,Sunder S, Makharia A,et al. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimonyresistant strains of Leishmania donovani. J Infect Dis, 1999,180 (2) :564-567
8Ouellette M. Biochemical and molecular mechanisms of drug resistance in parasites. Trop Med Int Health, 2001,6( 11 ): 874-882
9Roberts W L, Rainey P M. Antimony quantification in leishmania by electrothermal atomic absorption spectroscopy. Anal Biochem, 1993, 211(1):1-6
10Lugo de Yarbuh A, Anez N, Petit de Pena Y, et al. Antimony determination in tissues and serum of hamsters infected with Leishmania garnhami and treated with meglumine antimoniate. Ann Trop Med Parasitol, 1994,88( 1 ): 37-41
